NO20022142L - Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon - Google Patents

Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon

Info

Publication number
NO20022142L
NO20022142L NO20022142A NO20022142A NO20022142L NO 20022142 L NO20022142 L NO 20022142L NO 20022142 A NO20022142 A NO 20022142A NO 20022142 A NO20022142 A NO 20022142A NO 20022142 L NO20022142 L NO 20022142L
Authority
NO
Norway
Prior art keywords
dopamine
salt
treatment
receptor agonists
dependent hypertension
Prior art date
Application number
NO20022142A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022142D0 (no
Inventor
Bernd Muehlbauer
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of NO20022142L publication Critical patent/NO20022142L/no
Publication of NO20022142D0 publication Critical patent/NO20022142D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20022142A 1999-11-04 2002-05-03 Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon NO20022142D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19953254 1999-11-04
PCT/EP2000/010770 WO2001032263A1 (fr) 1999-11-04 2000-10-31 Utilisation d'antagonistes du recepteur d3 de la dopamine pour la therapie de l'hypertonie liee a l'absorption de sel

Publications (2)

Publication Number Publication Date
NO20022142L true NO20022142L (no) 2002-05-03
NO20022142D0 NO20022142D0 (no) 2002-05-03

Family

ID=7928007

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022142A NO20022142D0 (no) 1999-11-04 2002-05-03 Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon

Country Status (15)

Country Link
EP (1) EP1233815A1 (fr)
JP (1) JP2003513053A (fr)
KR (1) KR20020062300A (fr)
CN (1) CN1387450A (fr)
AU (1) AU1390801A (fr)
BR (1) BR0015310A (fr)
CA (1) CA2389643A1 (fr)
CZ (1) CZ20021521A3 (fr)
HU (1) HUP0203024A2 (fr)
IL (1) IL149266A0 (fr)
MX (1) MXPA02004103A (fr)
NO (1) NO20022142D0 (fr)
RU (1) RU2002114818A (fr)
WO (1) WO2001032263A1 (fr)
ZA (1) ZA200204455B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1180599A1 (fr) * 2000-08-16 2002-02-20 Siemens Building Technologies AG Dispositif de sécurité pour une pompe pouvant être utilisée dans une transmission à fluide
JP2010184889A (ja) * 2009-02-12 2010-08-26 Nihon Univ 高血圧症予防治療薬
WO2011047350A2 (fr) * 2009-10-16 2011-04-21 David Helton Traitement des vomissements

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008219A (en) * 1995-03-27 1999-12-28 Smithkline Beech P.L.C. Bicyclic amine derivatives and their use as anti-psychotic agents
FR2742149B1 (fr) * 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques

Also Published As

Publication number Publication date
HUP0203024A2 (hu) 2003-02-28
IL149266A0 (en) 2002-11-10
KR20020062300A (ko) 2002-07-25
AU1390801A (en) 2001-05-14
NO20022142D0 (no) 2002-05-03
ZA200204455B (en) 2003-09-04
CN1387450A (zh) 2002-12-25
EP1233815A1 (fr) 2002-08-28
MXPA02004103A (es) 2003-08-20
WO2001032263A1 (fr) 2001-05-10
RU2002114818A (ru) 2004-01-10
JP2003513053A (ja) 2003-04-08
BR0015310A (pt) 2002-07-09
CA2389643A1 (fr) 2001-05-10
CZ20021521A3 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
NO20022925D0 (no) EP4 reseptor selektive agonister for behandling av osteoporose
NO20032360D0 (no) EP4 reseptor selektive agonister for behandling av osteoporose
PT1189916E (pt) N-pirazole agonistas do receptor a2a
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20022105D0 (no) Positive modulatorer av nikotinreseptoragonister
NO20030213D0 (no) Anvendelse av D2/D3 reseptor-agonister for behandling av fibromyalgi
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
NO20034122D0 (no) Sammensmeltede pyridinderivater for anvendelse som vanilloidreseptorantagonister for behandling av smerte
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
DK1208095T3 (da) Dibenzopyraner som glucocorticoidreceptorantagonister til behandling af diabetes
NO20013381D0 (no) 2-oksybenzoksazinonderivater for behandling av fedme
NO20016246L (no) Selektiv iGluR5 reseptorantagonist for behandling av migrene
NO20020574D0 (no) Substituerte 1,5-dihydropyrrol-2-onderivater som er virksomme som NMDA-reseptorantagonister for behandlingen av smertetilstanden
DE60028368D1 (de) Agonisten des peroxisom aktivator-responsiven rezeptors
NO20013997L (no) Reseptoranalyse
NO20032304D0 (no) Anvendelse av selektive dopamin D4-reseptoragonister for behandling av seksuell dysfunksjon
NO20022142L (no) Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon
NO20021295L (no) Nikotinsyreacetylcholin-reseptor
DE60023020T2 (de) Positive modulatoren von nicotinrezeptor-agonisten
ID30381A (id) Penggunaan arilalkanoilpiridazina
NO20014904L (no) Fremgangsmåte for forspenning av en ankerline
SE9904449D0 (sv) Activtor of the vanilloid receptor
TR199901524A3 (tr) Endojen evrede melatoninin serbest kalmasi.
DK1200402T3 (da) Substituerede 1,5-dihydropyrrol-2-on-derivater med virkning som NMDA-receptorantagonister til behandling af smertetilstande

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application